Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

foundation

Overview

PCF TACTICAL Awards

Overview: TACTICAL stands for "Targeted α-particle Therapy to Radically Improve Cancer Lethality." These awards fund accelerated platforms for innovative cancer research approaches.

Focus Areas:

  • Targeted alpha-particle therapy

  • Radioligand therapy (RLT)

  • Novel treatment targets (ROR1, DLL3, PSMA, FAP)

  • Biomarker development and resistance mechanisms

  • Theranostic approaches

  • Advanced imaging

  • Lethal prostate cancer treatment
  • Scope:

  • International multi-institutional teams

  • Preclinical and clinical trial components

  • 7-10 year translational pathway

  • Potential for commercialization and regulatory approval
  • Research Areas:

  • Novel chemistry approaches for targeting prostate cancer

  • Lead-212 alpha-emitting radioactive payloads

  • Resistance mechanisms to treatment

  • Patient biomarker characterization

  • In-human biodistribution studies
  • Contact:
    Prostate Cancer Foundation
    1250 Fourth Street
    Santa Monica, CA 90401
    Phone: 1.800.757.CURE (2873)
    Email: [email protected]

    Focus Areas & Funding Uses

    Fields of Work

    cancerscience-research

    Categories

    Browse similar grants by category

    Related Grants

    Similar grants from this funder and related organizations

    Ready to apply for PCF TACTICAL Awards?

    Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.